Catalyst Wire Dossier Catalyst Wire Dossier

Meropenem

Meropenem · Qilu Antibiotics Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

101 regulatory and trial events tracked for Meropenem, covering 2008-06-04 to 2026-08-10. Get the full timeline:

Most recent: FDA Approved: MEROPENEM — Supplemental Application (WG Critical Care, LLC)

See pricing